Is eczema a a symptom?
summary
Eczema is a severe skin inflammatory reaction caused by a variety of internal and external factors. There are three stages: acute, subacute and chronic. In acute stage, there is exudation tendency, while in chronic stage, there is infiltration and hypertrophy. Some patients directly present with chronic eczema. Skin lesions are characterized by pleomorphism, symmetry, pruritus and recurrent attacks. Is eczema a a symptom? Let's talk about it
Is eczema a a symptom?
The lesions of acute eczema are mostly dense miliary papules, papules or small blisters at the beginning, the base is flushed, and gradually merge into a piece. Due to scratching, the top of papules, papules or blisters is scratched and broken, showing obvious punctate exudation and small erosive surface, and the edge is unclear.
If secondary infection, inflammation is more obvious, can form pustules, purulent callus, folliculitis, furuncle, etc. Conscious severe itching. Most of them are distributed symmetrically in the head and face, behind the ear, distal extremities, scrotum, perianal, etc.
Chronic eczema often turns into chronic eczema because of repeated attacks of acute and subacute eczema; It can also start with chronic eczema. It is characterized by skin thickening, infiltration, brownish red or pigmentation, rough surface, covered with scales, or scab due to scratch. The pruritus was severe. Common in the leg, hand, foot, cubital fossa, popliteal fossa, vulva, anus and other places. The course of disease is indefinite, easy to relapse, long-lasting.
matters needing attention
Appropriate dosage forms and drugs should be selected according to the skin lesions. Acute eczema local normal saline, 3% boric acid or 1:2000-1:10000 potassium permanganate solution washing, wet compress, calamine lotion convergence, protection. Subacute and chronic eczema should be treated with appropriate glucocorticoid cream, tar preparations or immunomodulators, such as tacrolimus ointment and pimecrolimus ointment. Antibiotics were added to the patients with secondary infection.










